Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease

被引：0
|
作者：
Yang, Monica [1 ]
Lee, Seoyeon [1 ]
Neely, Jessica [2 ]
Sirota, Marina [1 ]
Wolters, Paul [1 ]
机构：
[1] UCSF, Sf, CA USA
[2] UCSF Benioff Childrens Hosp, San Francisco, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2022年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1539
引用
下载
收藏
页码：3048 / 3049
页数：2
相关论文
共 50 条
  • [1] Gene expression meta-analysis reveals aging and cellular senescence signatures in scleroderma-associated interstitial lung disease
    Yang, Monica M.
    Lee, Seoyeon
    Neely, Jessica
    Hinchcliff, Monique
    Wolters, Paul J.
    Sirota, Marina
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [2] Update on scleroderma-associated interstitial lung disease
    Fan, Ming-Hui
    Feghali-Bostwick, Carol A.
    Silver, Richard M.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (06) : 630 - 636
  • [3] Effect Of Mycophenolate Mofetil On Scleroderma-Associated Interstitial Lung Disease
    Baqir, M.
    Makol, A.
    Osborn, T. G.
    Bartholmai, B.
    Ryu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] A New Era in the Treatment of Scleroderma-associated Interstitial Lung Disease?
    Launay, David
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1619 - 1621
  • [5] SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Silver, R.
    RHEUMATOLOGY, 2012, 51 : I12 - I12
  • [6] Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
    Gisela E Lindahl
    Carmel JW Stock
    Xu Shi-Wen
    Patricia Leoni
    Piersante Sestini
    Sarah L Howat
    George Bou-Gharios
    Andrew G Nicholson
    Christopher P Denton
    Jan C Grutters
    Toby M Maher
    Athol U Wells
    David J Abraham
    Elisabetta A Renzoni
    Respiratory Research, 14
  • [7] Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease
    Lindahl, Gisela E.
    Stock, Carmel J. W.
    Xu Shi-Wen
    Leoni, Patricia
    Sestini, Piersante
    Howat, Sarah L.
    Bou-Gharios, George
    Nicholson, Andrew G.
    Denton, Christopher P.
    Grutters, Jan C.
    Maher, Toby M.
    Wells, Athol U.
    Abraham, David J.
    Renzoni, Elisabetta A.
    RESPIRATORY RESEARCH, 2013, 14
  • [8] Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease
    Silver, R. M.
    Wilson, D. A.
    Akter, T.
    Atanelishvili, I.
    Huggins, J. T.
    Kajdasz, K.
    Highland, K. B.
    Nietert, P. J.
    Bogatkevich, G. S.
    ACR OPEN RHEUMATOLOGY, 2019, 1 (07) : 403 - 411
  • [9] Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab
    McGonagle, D.
    Tan, A. L.
    Madden, J.
    Rawstron, A. C.
    Rehman, A.
    Emery, P.
    Thomas, S.
    RHEUMATOLOGY, 2008, 47 (04) : 552 - 553
  • [10] Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
    Zamora, Ana C.
    Wolters, Paul J.
    Collard, Harold R.
    Connolly, M. Kari
    Elicker, Brett M.
    Webb, W. Richard
    King, Talmadge E., Jr.
    Golden, Jeffrey A.
    RESPIRATORY MEDICINE, 2008, 102 (01) : 150 - 155
12345